Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · IEX Real-Time Price · USD
105.25
-0.21 (-0.20%)
At close: May 31, 2024, 4:00 PM
105.15
-0.10 (-0.10%)
After-hours: May 31, 2024, 6:56 PM EDT
Jazz Pharmaceuticals Stock Forecast
Stock Price Forecast
The 14 analysts with 12-month price forecasts for JAZZ stock have an average target of 191.43, with a low estimate of 131 and a high estimate of 230. The average target predicts an increase of 81.88% from the current stock price of 105.25.
Analyst Consensus: Buy
* Price targets were last updated on May 3, 2024.
Analyst Ratings
The average analyst rating for JAZZ stock from 15 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 2 | 4 | 6 | 7 | 7 | 7 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 12 | 14 | 15 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $200 | Strong Buy | Reiterates | $200 | +90.02% | May 3, 2024 |
| Barclays | Barclays | Buy Maintains $230 → $200 | Buy | Maintains | $230 → $200 | +90.02% | May 3, 2024 |
| Needham | Needham | Strong Buy Reiterates $222 | Strong Buy | Reiterates | $222 | +110.93% | May 2, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $180 | Buy | Reiterates | $180 | +71.02% | Apr 10, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $170 → $190 | Buy | Maintains | $170 → $190 | +80.52% | Mar 22, 2024 |
Financial Forecast
Revenue This Year
4.13B
from 3.83B
Increased by 7.77%
Revenue Next Year
4.43B
from 4.13B
Increased by 7.26%
EPS This Year
18.91
from 6.10
Increased by 210.08%
EPS Next Year
21.16
from 18.91
Increased by 11.88%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 4.3B | 4.9B | 5.3B | 5.6B | 6.2B |
| Avg | 4.1B | 4.4B | 4.6B | 4.9B | 5.2B |
| Low | 3.9B | 3.9B | 4.1B | 4.2B | 4.1B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 12.6% | 18.3% | 20.3% | 20.8% | 26.7% |
| Avg | 7.8% | 7.3% | 4.9% | 5.2% | 5.7% |
| Low | 2.3% | -5.6% | -6.5% | -9.5% | -16.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 20.16 | 25.04 | 28.47 | 28.93 | 33.44 |
| Avg | 18.91 | 21.16 | 22.12 | 23.48 | 24.74 |
| Low | 17.79 | 15.78 | 16.11 | 15.67 | 14.83 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 230.5% | 32.4% | 34.5% | 30.8% | 42.4% |
| Avg | 210.1% | 11.9% | 4.5% | 6.2% | 5.3% |
| Low | 191.6% | -16.6% | -23.9% | -29.2% | -36.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.